Shi Helen, Stark Allison, Maity Aloke, Shah Abhishek, Manganelli Joseph, Baichoo Paula, Korchevsky Svetlana, Suthar Pooja, Zhang Chenshu, Rikin Sharon
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Medicine, Montefiore Health System, Bronx, NY, USA.
J Hum Hypertens. 2025 Jun;39(6):422-424. doi: 10.1038/s41371-025-01025-5. Epub 2025 May 6.
In this implementation science study evaluating the feasibility and effectiveness of a remote patient monitoring program for hypertension, we found that most, but not all of patients received the intended program components of clinical pharmacist outreach and medication titration. Despite feasibility challenges, remote-patient monitoring for hypertension was effective at reducing systolic blood pressure by ≥ 5 mmHg in (64%) and 346 (71%) patients by 3 and 6 months of enrollment respectively. Unexpectedly, chi-square and multivariate logistic regressions analysis showed that the clinical pharmacist outreach, was not associated with blood pressure improvement, but that patient engagement and medication titration were associated with blood pressure improvement. These results suggest that other unmeasured behavioral and lifestyle changes may be a large driver of BP improvement and that while RPM-HTN is a worthwhile intervention, it may not require all ancillary components to deliver meaningful results.
在这项评估高血压远程患者监测项目可行性和有效性的实施科学研究中，我们发现大多数（但并非所有）患者接受了临床药师随访和药物滴定等预期的项目组成部分。尽管存在可行性挑战，但高血压远程患者监测在入组3个月和6个月时分别使（64%）的患者和346名（71%）的患者收缩压有效降低≥5 mmHg。出乎意料的是，卡方检验和多变量逻辑回归分析表明，临床药师随访与血压改善无关，但患者参与度和药物滴定与血压改善有关。这些结果表明，其他未测量的行为和生活方式改变可能是血压改善的主要驱动因素，虽然高血压远程患者监测是一项有价值的干预措施，但可能并不需要所有辅助组成部分就能产生有意义的结果。
